Cartesian Therapeutics, Inc. · NASDAQ:RNAC

JPMorgan Chase & Co reported a 6.10% stake in Cartesian Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2025 · Filed Apr 25, 2025

JPMorgan Chase & Co reported a 6.10% stake in Cartesian Therapeutics, Inc., 1,675,636 shares, as a passive investor on Mar 31, 2025. Filed Apr 25, 2025 (Schedule 13G).

Stake
6.10%
Shares
1,675,636
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
JPMORGAN CHASE & CO.6.10%1,675,636

Source

View original at SEC

Related